Medically reviewed by Aviv Joshua, MS, RDN Key Takeaways Adults should get 75 to 90 milligrams (mg) of vitamin C every ...

Biologics, including GLP-1 analogs and PCSK9 inhibitors, are advancing treatment options for metabolic syndrome components like type 2 diabetes and dyslipidemia. GLP-1 receptor agonists improve ...

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening disease. It causes scarring of the connective tissue between the functional ...

Share on Pinterest Scientists have found a link between an everyday chemical and liver disease and cancer. Alfred Evelina/500px/Getty Images Metabolic dysfunction-associated steatotic liver disease ...

The National Center for Health Statistics reports that the percentage of Americans aged 65+ with obesity has doubled to 40% for both men and women. While pharmacotherapies like GLP-1 receptor agonists ...

Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...

Researchers reveal that people who skip breakfast are more likely to develop metabolic syndrome and its key components: belly fat, high blood pressure, high blood sugar, and high cholesterol. This ...

A significant number of people had asymptomatic liver disease, according to a large-scale European study. The LIVERSCREEN study is assessing a feasible, non-invasive screening strategy for liver ...

Metabolic syndrome was tied to a 24% higher risk of young-onset dementia in a population-based cohort study. Risks of vascular dementia and Alzheimer's also rose in younger people with metabolic ...

Tony Arenas, who has cystic fibrosis and received a double lung transplant, was recently diagnosed with stage 4 colon cancer. Despite a lifetime of medical challenges, Arenas maintains a determined ...

Researchers have uncovered how metabolic reprogramming contributes to renal fibrosis in IgG4-related disease (IgG4-RD), a systemic immune-mediated disorder. The review, published in a leading journal, ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...